Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
RBNZ Holds Interest Rates Steady but Signals More Hikes Ahead in 2026
Wall Street Futures Steady as AI Rally Offsets Middle East Tensions
European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market
Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge
Gold Prices Edge Higher as Markets Monitor U.S.-Iran Peace Talks
BOJ Governor Ueda Warns Oil Price Shock Could Trigger Persistent Inflation
U.S. Launches New Strikes on Iran as Trump Signals Peace Deal Uncertainty
Canada and Germany Advance Major LNG Supply Partnership
CTOC Goes Live on Bitget Wallet Trading, Expanding Global Access to AI-Powered Healthcare Data Ecosystem
Gold Prices Slip as Stronger Dollar and Iran Peace Talk Uncertainty Weigh on Market
ECB’s Philip Lane Warns Middle East Conflict Could Keep Inflation Elevated
Nikkei Hits Record High as AI Chip Stocks Power Japan Market Rally
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments
S&P 500 Hits Record High as Tech Rally Slows Amid Iran Peace Uncertainty
Asian Markets Slide as New U.S. Strikes on Iran Spark Investor Caution 



